Literature DB >> 22349711

Pitfalls in radiation oncology. "Myocardial metastasis" in PET-CT after palliative radiation treatment of the left 5th rib.

P Kröpil1, W Budach, E Bölke, P A Gerber, F Zinnmann, H Hautzel, G Antoch, A Scherer, C Matuschek.   

Abstract

BACKGROUND: Positron emission tomography-computed tomography (PET-CT) is a useful diagnostic tool to detect metastases in patients with malignancy. False positives have been reported in cases of inflammation and tissue regeneration. CASE REPORT: Over a period of 2 years, a 32-year-old woman with hepatocellular carcinoma and multiple bone metastases received three treatments of radiation therapy to a bone metastasis in the 5th left rib. Restaging with [18F]fluorodeoxyglucose (FDG) PET-CT showed increased uptake within the cardiac apex highly suspicious for a myocardial metastasis. Because the patient was asymptomatic, additional magnetic resonance imaging (MRI) of the heart was performed demonstrating radiation-associated changes but no evidence for metastases.
CONCLUSION: PET-CT is a well-established diagnostic tool in metastatic diseases but its results should always be correlated with the clinical picture of the patient and previous treatments to rule out false positives.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349711     DOI: 10.1007/s00066-011-0059-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  18 in total

Review 1.  Combined PET/MRI: a new dimension in whole-body oncology imaging?

Authors:  Gerald Antoch; Andreas Bockisch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

2.  Pitfalls in positron emission tomography/computed tomography imaging: causes and their classifications.

Authors:  Tian-ran Li; Jia-he Tian; Hui Wang; Zi-qian Chen; Chun-lei Zhao
Journal:  Chin Med Sci J       Date:  2009-03

Review 3.  [Cardiac pathologies incidentally detected with non-gated chest CT].

Authors:  A Scherer; G Choy; P Kröpil; R S Lanzman; U Mödder; S Abbara
Journal:  Rofo       Date:  2009-10-27

4.  Morbidity of ischemic heart disease in early breast cancer 15-20 years after adjuvant radiotherapy.

Authors:  G Gyenes; T Fornander; P Carlens; L E Rutqvist
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-03-30       Impact factor: 7.038

Review 5.  PET-MRI fusion in head-and-neck oncology: current status and implications for hybrid PET/MRI.

Authors:  Denys J Loeffelbein; Michael Souvatzoglou; Veronika Wankerl; Axel Martinez-Möller; Julia Dinges; Markus Schwaiger; Ambros J Beer
Journal:  J Oral Maxillofac Surg       Date:  2011-05-20       Impact factor: 1.895

6.  Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients.

Authors:  Edwin Bölke; Gisela Schieren; Stephan Gripp; Gerald Steinbach; Matthias Peiper; Klaus Orth; Christiane Matuschek; Maximilian Pelzer; Guido Lammering; Ruud Houben; Christina Antke; Lars Christian Rump; Rodrigo Mota; Peter Arne Gerber; Patrick Schuler; Thomas K Hoffmann; Ethelyn Rusnak; Derik Hermsen; Wilfried Budach
Journal:  Strahlenther Onkol       Date:  2011-02-24       Impact factor: 3.621

7.  [Prevalence and clinical significance of incidental cardiac findings in non-ECG-gated chest CT scans].

Authors:  M Quentin; P Kröpil; S Steiner; R S Lanzman; D Blondin; F Miese; G Choy; S Abbara; A Scherer
Journal:  Radiologe       Date:  2011-01       Impact factor: 0.635

8.  Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT.

Authors:  Mylene T Truong; Jeremy J Erasmus; Reginald F Munden; Edith M Marom; Bradley S Sabloff; Gregory W Gladish; Donald A Podoloff; Homer A Macapinlac
Journal:  AJR Am J Roentgenol       Date:  2004-10       Impact factor: 3.959

Review 9.  PET/CT for the staging and follow-up of patients with malignancies.

Authors:  T D Poeppel; B J Krause; T A Heusner; C Boy; A Bockisch; G Antoch
Journal:  Eur J Radiol       Date:  2009-04-29       Impact factor: 3.528

Review 10.  Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions.

Authors:  Amer Shammas; Ruth Lim; Martin Charron
Journal:  Radiographics       Date:  2009 Sep-Oct       Impact factor: 5.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.